Colon Cancer News
News on Colon Cancer continually updated from thousands of sources around the net.
9 hrs ago | BioSpace
A promising treatment in advanced stage lung cancer After convincing Phase 2 results observed in a United States trial, OSE Pharma's team have received authorisation to start a new multi-centre phase 3 trial with TexopiA on 500 patients in Europe and in the United States. TexopiA , a personalised treatment, is designed to benefit patients who carry the tissue marker HLA A2 who are affected by invasive or metastatic cancers.
13 hrs ago | WEAU-TV Eau Claire
Colorectal cancer is the second leading cause of cancer death in our country, claiming 50 thousand lives each year. Screening could cut that number dramatically, but according to the CDC many adults are not following those recommendations.
Tomorrow is World Sepsis Day, an opportunity to turn the spotlight on a devastating disease that is common but unfamiliar. Once it takes hold, up to a third of patients die from it, says the Sepsis Alliance.
Diem Brown is grateful to be alive as she battles her third round of cancer, but lost 25 pounds during the past month and now weighs a frail 100 pounds. Brown underwent two emergency surgeries to remove cancer from her colon and stomach and faces a long recovery ahead, including chemotherapy, People reported Thursday.
Genomic Health, Inc. today announced that PharmacoEconomics published positive results from a health economic analysis suggesting that use of the Oncotype DX colon cancer test may result in a significant reduction in direct medical costs and improve patient quality of life by helping them avoid side effects of unnecessary treatment. "By providing quantitative information which has not been available with conventional measures, as demonstrated in this analysis, the Oncotype DX colon cancer test is likely to lead to both savings in direct medical costs and improved patient well-being," said Steven Alberts, M.D., chair, division of Medical Oncology at the Mayo Clinic, Rochester, Minn.
Eli Lilly and Co said its colon cancer drug extended survival compared to a placebo, in a late stage trial. The study tested the drug, ramucirumab in combination with chemotherapy, against a placebo plus chemotherapy, in previously treated patients with advanced or metastatic colon cancer.
It's really too early to know what the mayor has, and whether it's a form of cancer. The reality is that there are hundreds of questions that still require an answer in order to make a diagnosis.
Mayor Rob Ford will have to wait a week to find out the results of a biopsy on his abdominal tumor, the controversial politician's doctor said. Dr. Zane Cohen, a colorectal surgeon at Mount Sinai hospital, said Thursday that Ford has a mass in his abdomen and they have to find what it is and how to proceed.
"This important milestone about reimbursement, the PCA3 test inclusion in American and European guidelines, and several business-related actions taken in the last months lead us to believe that shareholders should expect a positive impact on PCA3 future sales and royalties," said Dr. , President and Chief Medical Officer of the Corporation. The results of the VITAR II retrospective clinical study of the Previstage GCC test were published in the confirmed that the GCC status in lymph nodes of 366 stage II colon cancer patients can classify up to 60% of them as having a very low risk of recurrence at five years suggesting, that these patients may gain little benefit from toxic adjuvant chemotherapy.
The information provided by the hospital caring for Toronto Mayor Rob Ford on Wednesday evening was very vague - likely deliberately so. A CT scan had revealed the mayor had a tumour in his abdomen.
At a speech on Saturday Mayor Rob Ford talked about the immeasurable value of health and the perspective that can be gained when it's put at risk. "Once your health goes.
Q. I heard there is a DNA test for colon cancer. Can I cancel my colonoscopy? Please?! - Stephen G., Colorado Springs, Colorado A. Sit tight! The news about a fecal DNA test to spot hemoglobin and mutant DNA that might indicate the presence of colon cancer and adenomatous polyps is great news, but it doesn't eliminate the need for colonoscopies.
Updated: Mon Sep 15, 2014 11:17 am
Copyright © 2014 Topix LLC